Table 4. Cox regression analysis of pre-transplant variables associated with 3-month mortality in not-transplanted group.
Alive | Dead | Multivariate | ||||||
---|---|---|---|---|---|---|---|---|
38 | 23 | p | B | HR | 95% CI | |||
Body temperature | 37.0 | 32–39 | 35.0 | 32–39 | 0.539 | 0.131 | 1.14 | 0.75–1.73 |
Heart rate (bpm) | 105 | 32–150 | 130 | 100–160 | 0.050 | 0.023 | 1.02 | 1.00–1.05 |
A-a Gradient (mmHg) | 39.55 | -57–524 | 157.3 | -79–563 | 0.765 | -0.01 | 0.99 | 0.99–1.00 |
Norepinephrine dose (mcg/min) | 0.00 | 0–37 | 21.33 | 0–130 | 0.012 | 0.020 | 1.02 | 1.00–1.04 |
Albumin (g/L) | 28 | ± 6.17 | 21 | ± 4.66 | 0.851 | -0.01 | 0.99 | 0.91–1.08 |
APTT (sec) | 43 | 27–101 | 80 | 30–250 | 0.963 | 0 | 1 | 0.99–1.02 |
pH | 7.387 | ± 0.96 | 7.270 | ± 0.15 | 0.505 | -1.57 | 0.21 | 0.00–21.2 |
Potassium (mmol/L) | 3.4 | 2.3–5.2 | 3.6 | 3.0–5.6 | 0.328 | -0.48 | 0.62 | 0.24–1.62 |
BE (mmol/L) | -3 | ± 5.86 | -9.2 | ± 6.64 | 0.268 | -0.04 | 0.95 | 0.87–1.04 |
Lactate (mmol/L) | 3.8 | 0.8–14.6 | 8.8 | 2.6–20.3 | 0.620 | -0.03 | 0.96 | 0.83–1.12 |
SOFA | 8.5 | ± 3.55 | 13.5 | ± 3.01 | 0.762 | -0.04 | 0.96 | 0.71–1.28 |
CLIF-C OF | 11.5 | 9–16 | 15 | 12–16 | 0.014 | 0.391 | 1.48 | 1.08–2.02 |
CLIF-C ACLF | 45.3 | ± 14.3 | 58.7 | ± 9.3 | 0.248 | -0.03 | 0.97 | 0.91–1.03 |